NCT02447887 · Interventional trial
Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Metastatic Renal Cell Carcinoma, RCC
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory